Samuel Godar is founder and President of BioTest4U, Inc. He obtained PhD from Immunology/Biochemistry at the University of Vienna in Austria. He did his postdoctoral research at the Whitehead Institute for Biomedical Research / MIT, Cambridge, MA. Dr. Godar then became Assistant Professor at the Department of Cancer Biology, College of Medicine, University of Cincinnati, Cincinnati, OH.
In 2013 he founded biotech firm Biotest4U, which is focused on experimental diagnostics and treatment of primary and metastatic cancers.
President, BioTest4u, Inc.
Experimental Diagnostics Company, Covington, KY/OH
Department of Cancer Biology, College of Medicine, University of Cincinnati, Cincinnati, OH
Whitehead Institute for Biomedical Research / MIT, Cambridge, MA
• Kim K., Godarova A., Seedle K., Kim M., Ince T.A., Wells S.I. and Godar S.: Rb Suppresses Collective Invasion, Circulation and Metastasis of Breast Cancer Cells in CD44-Dependent Manner (2013). PLOS One (8) e80950.
• Godar S., Ince T.A., Bell G. W., Feldser D., Liu Donaher J., Bergh J., Liu A., Miu K., Watnick R.S., Reinhardt F., McAllister S.A., Jacks T. and Weinberg R.A. Growth Inhibitory and Tumor-Suppressive Functions of p53 Depend on its Repression of CD44 Expression (2008). Cell. (134) 62-73.
• Ince T.A , Richardson A.L., Bell G.W., Saitoh M., Godar S., Karnoub A.E., Iglehart J.D. and Weinberg R.A. (2007). Transformation of Different Human Breast Epithelial Cell Types Leads to Distinct Tumor Phenotypes. Cancer Cell. (12) 160-170.